The Importance of Targeting Therapies for Patients With Interstitial Cystitis

By Rob Dillard - Last Updated: February 5, 2025

At Urology on the Beach, DocWire News spoke with J.Quentin Clemens, MD, University of Michigan Health, to learn more about interstitial cystitis (IC), the current treatment landscape around this disease, and how IC impacts quality of life.

Navigating the Obstacles of Treating Male Patients With Testosterone Replacement Therapy

Rob DillardUrology | February 5, 2025

Larry Lipshultz, MD, discusses the concurrent use of testosterone replacement therapy, especially as it pertains to couples.

Cardiometabolic Index Can Predict Risk of Stress Urinary Incontinence in Women

Rob DillardUrology | January 16, 2025

A new study assessed the link between the cardiometabolic index and the risk of SUI in women.

Jordana JampelUrology | December 9, 2024

Bidirectional Mendelian randomization was used and a multi-trait analysis of GWAS was conducted.

Pelvic Floor Muscle Pain Associated With Dyspareunia, Not Bladder Capacity or Glomerulation Grade

Jordana JampelUrology | December 9, 2024

Objective assessment items included bladder wall thickness in CT, urodynamic parameters, and maximum bladder capacity.

Impact of Acute Urinary Retention on Postoperative Complications After Transurethral Resection of Prostate in Benign Prostatic Hyperplasia

Jordana JampelUrology | December 4, 2024

Having AUR correlated with higher urinary symptom prevalence.

The Importance of Targeting Therapies for Patients With Interstitial Cystitis

Related Posts